Abstract

Inflammation is associated with many diseases, so the development of an excellent near infrared fluorescent (NIRF) and photoacoustic (PA) dual-modality probe is crucial for the accurate diagnosis and efficacy evaluation of inflammation. However, most of the current NIRF/PA scaffolds are based on repurposing existing fluorescent dye platforms that exhibit non-optimal properties for both NIRF and PA signal outputs. Herein, we developed a novel dye scaffold QL-OH by optimizing the NIRF and PA signal of classical hemicyanine dyes. Based on this optimized dye, we developed the first NIRF/PA dual-mode carbon monoxide (CO) probe QL-CO for noninvasive and sensitive visualization of CO levels in deep inflammatory lesions in vivo. The novel probe QL-CO exhibited rapid and sensitive NIRF775/PA730 dual activation responses toward CO. In addition, the CO-activated probe QL-CO was successfully used for the diagnosis of inflammation and evaluation of anti-inflammation drug efficacy in living mice though the NIRF/PA dual-mode imaging technology for the first time. More importantly, the probe QL-CO could accurately locate the deep inflammatory lesion tissues (≈1 cm) in mice and obtain 3D PA diagnostic images with deep penetration depth and spatial resolution. Therefore, the new NIRF/PA dual-mode probe QL-CO has high potential for deep-tissue diagnosis imaging of CO in vivo. These findings may provide a new tool and approach for future research and diagnosis of CO-associated diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call